Aeolus to test efficacy of drug against radiation exposure

Aeolus Pharmaceuticals is set to test in primates the efficacy of AEOL 10150, a compound for treating lung damage caused by radiation exposure. The study also aims to create an animal model that can be reviewed by the FDA in approving a product for pulmonary acute radiation syndrome. The company submitted a white paper to the Biomedical Advanced Research and Development Authority to request funding to advance development of the drug candidate.

View Full Article in: (free registration) · United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA